← All patents

US20230128075A1

Monoclonal antibodies targeting hsp70 and therapeutic uses thereof

University of Texas System

Abstract

Provided herein are agents, such as antibodies and chimeric antigen receptors, that target HSP70. Methods of treating cancer are provided, comprising administering to a patient in need thereof an effective amount of an HSP70-targeting agent. The HSP70-specific antibody may enhance uptake of HSP70 …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Robert Z. Orlowski
Priority date
March 27, 2020
Filing date
March 26, 2021
Publication date
April 27, 2023
Language
en
Metadata fetched
August 29, 2026 00:31